Assessment of metabolic risk factors and heart-healthy lifestyle in atherosclerotic coronary artery disease patients undergoing percutaneous coronary intervention after a 6-month follow-up

Ashemi Jazi, Seyed Mohammad H; Radmanesh, Armina; Sadeghi, Masoumeh; Mansouri, Asieh

Assessment of metabolic risk factors and heart-healthy lifestyle in atherosclerotic coronary artery disease patients undergoing percutaneous coronary intervention after a 6-month follow-up

Authors

¹ Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

² Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

³ Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Mortality due to acute coronary syndrome (ACS) has dramatically diminished because of performing life-saving interventions. This study aims to assess the metabolic risk factors and heart healthy lifestyle following the first episode of ACS under percutaneous coronary intervention (PCI) treatment after the 6-month follow-up. Materials and Methods: This is a longitudinal study conducted on 40 patients who underwent PCI because of the first episode of ACS. The patients' information including age, weight, abdominal circumference, smoking, functional capacity, patients' metabolic equivalent of task (METS), and laboratory tests including triglycerides (TGs), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), creatinine, fasting blood sugar (FBS), and hemoglobin A1C were recorded before discharge and reassessed after 6-month follow-up. Results: The patients were dominantly male (92.5%) with an average age of 56.8 ± 7.11 years. Physical activity and functional capacity (METS) significantly improved within 6 months (P = 0.019). BMI significantly improved; however, although the abdominal circumference decreased, it was not significant (P = 0.28). The number of smokers (P = 0.12) and the daily number of smoked cigarettes (P = 0.37) nonsignificantly decreased within 6 months. However, HDL-C (P = 0.013) and LDL-C (P = 0.027) changes were not desirable. TG, FBS, and blood pressure did not statistically significant change (P > 0.05). Conclusion: Although BMI, physical activity, and METS remarkably improved, waist circumference decreased nonsignificantly and lipid profile got worse paradoxically. Although this population is limited for generalization, this study shows that we require further schedules to improve ACS secondary prevention practice in our community.

Keywords

References

1.	Piepoli MF, Corrà U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, et al. Secondary prevention through cardiac rehabilitation: From knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2010;17:1-7.
2.	Reese C, Nechwatal R, Farin E. What do rehabilitation patients expect from a telemedicine cardiac rehab aftercare? Results from interviews with rehabilitation patients. Z Evid Fortbild Qual Gesundhwes 2019;143:43-8.
3.	Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med 2016;4:256.
4.	Roggeri DP, Roggeri A, Rossi E, Cinconze E, De Rosa M, Maggioni AP, et al. Direct healthcare costs and resource consumption after acute coronary syndrome: A real-life analysis of an Italian subpopulation. Eur J Prev Cardiol 2014;21:1090-6.
5.	Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. Journal of the American College of Cardiology. 2016;67:1-2.
6.	Brook RD. Is air pollution a cause of cardiovascular disease? Updated review and controversies. Rev Environ Health 2007;22:115-37.
7.	Stejskal D, Václavík J, Lacnák B, Prosková J. Aspirin resistance measured by cationic propyl gallate platelet aggregometry and recurrent cardiovascular events during 4 years of follow-up. Eur J Intern Med 2006;17:349-54.
8.	Arroyo-Johnson C, Mincey KD. Obesity epidemiology worldwide. Gastroenterol Clin North Am 2016;45:571-9.
9.	Davis EF, Lewandowski AJ, Aye C, Williamson W, Boardman H, Huang RC, et al. Clinical cardiovascular risk during young adulthood in offspring of hypertensive pregnancies: Insights from a 20-year prospective follow-up birth cohort. BMJ Open 2015;5:e008136.
10.	Basu R, Krueger PM, Lairson DR, Franzini L. Lifetime medical expenditures among hypertensive men and women in the United States. Womens Health Issues 2011;21:246-53.
11.	Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-52.
12.	Gorter PM, Olijhoek JK, van der Graaf Y, Algra A, Rabelink TJ, Visseren FL, et al. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis 2004;173:363-9.
13.	Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63:225-32.
14.	Murase T, Okubo M, Amemiya-Kudo M, Hiraga T, Oka J, Shimada M, et al. Impact of markedly elevated serum lipoprotein (a) levels (≥100 mg/dL) on the risk of coronary heart disease. Metabolism 2007;56:1187-91.
15.	Nichols S, Gleadall-Siddall DO, Antony R, Clark AL, Cleland JG, Carroll S, Ingle L. Estimated peak functional capacity: an accurate method for assessing change in peak oxygen consumption after cardiac rehabilitation?. Clinical Physiology and Functional Imaging. 2018;38:681-8.
16.	Delshad M, Ghanbarian A, Ghaleh NR, Amirshekari G, Askari S, Azizi F. Reliability and validity of the modifiable activity questionnaire for an Iranian urban adolescent population. Int J Prev Med 2015;6:3. [PUBMED] [Full text]
17.	Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: A systematic review and meta-analysis of prospective cohort studies. Lancet 2011;378:1297-305.
18.	Bakker EC, Nijkamp MD, Sloot C, Berndt NC, Bolman CA. Intention to abstain from smoking among cardiac rehabilitation patients: The role of attitude, self-efficacy, and craving. J Cardiovasc Nurs 2015;30:172-9.
19.	Berndt NC, Hayes AF, Verboon P, Lechner L, Bolman C, De Vries H. Self-efficacy mediates the impact of craving on smoking abstinence in low to moderately anxious patients: Results of a moderated mediation approach. Psychol Addict Behav 2013;27:113-24.
20.	Berndt N, Bolman C, Mudde A, Verheugt F, de Vries H, Lechner L. Risk groups and predictors of short-term abstinence from smoking in patients with coronary heart disease. Heart Lung 2012;41:332-43.
21.	Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol 2016;67:1-2.
22.	Hambrecht R, Niebauer J, Marburger C, Grunze M, Kälberer B, Hauer K, et al. Various intensities of leisure time physical activity in patients with coronary artery disease: Effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol 1993;22:468-77.
23.	Gielen S, Laughlin MH, O'Conner C, Duncker DJ. Exercise training in patients with heart disease: Review of beneficial effects and clinical recommendations. Prog Cardiovasc Dis 2015;57:347-55.
24.	Kim KW, Kang SG, Song SW, Kim NR, Rho JS, Lee YA. Association between the time of length since smoking cessation and insulin resistance in asymptomatic Korean male ex-smokers. J Diabetes Res 2017;2017:6074760.
25.	Schwartz MG, Olsson AG, Szarek M, Sasiela WJ. Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome. Diabetes Care 2005;28:2508-13.
26.	Montazerifar F, Bolouri A, Mahmoudi Mozaffar M, Karajibani M. The prevalence of metabolic syndrome in coronary artery disease patients. Cardiol Res 2016;7:202-8.
27.	Parsa AF, Jahanshahi B. Is the relationship of body mass index to severity of coronary artery disease different from that of waist-to-hip ratio and severity of coronary artery disease? Paradoxical findings. Cardiovasc J Afr 2015;26:13-6.
28.	Koba S, Ayaori M, Uto-Kondo H, Furuyama F, Yokota Y, Tsunoda F, et al. Beneficial effects of exercise-based cardiac rehabilitation on high-density lipoprotein-mediated cholesterol efflux capacity in patients with acute coronary syndrome. J Atheroscler Thromb 2016;23:865-77.
29.	Redfors B, Généreux P, Witzenbichler B, Kirtane AJ, McAndrew T, Weisz G, et al. Bleeding severity after percutaneous coronary intervention. Circ Cardiovasc Interv 2018;11:e005542.

Advanced Biomedical Research